Samuelson Doug

Samuelson Doug is listed in filings as Chief Financial Officer at Kairos Pharma, Ltd.. This profile follows SEC Form 4 activity through Nov 26, 2025, including purchase activity. Recent filings connect the profile to Kairos Pharma, Ltd. (KAPA) and Sacks Parente Golf, Inc. (SPGC). The current snapshot covers public activity from Sep 12, 2024 to Nov 26, 2025. Reported amounts are shown as $3.8K to $108.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.